CXCL1 inhibits airway smooth muscle cell migration through the decoy receptor Duffy antigen receptor for chemokines

• Published in: The Journal of immunology (1950) 2014-08, Vol.193 (3), p.1416-1426
• Main Authors: Al-Alwan, Laila A, Chang, Ying, Rousseau, Simon, Martin, James G, Eidelman, David H, Hamid, Qutayba
• Format: Article
• Language: English
• Subjects: Airway Remodeling - immunology; Biomarkers - metabolism; Cell Migration Inhibition - immunology; Chemokine CXCL1 - metabolism; Chemokine CXCL1 - physiology; Chemokine CXCL2 - physiology; Duffy Blood-Group System - metabolism; Duffy Blood-Group System - physiology; Humans; MAP Kinase Signaling System - immunology; Primary Cell Culture; Receptors, Cell Surface - metabolism; Receptors, Cell Surface - physiology; Receptors, Interleukin-8B - metabolism; Receptors, Interleukin-8B - physiology
• ISSN: 0022-1767; 1550-6606
• DOI: 10.4049/jimmunol.1302860

Airway smooth muscle cell (ASMC) migration is an important mechanism postulated to play a role in airway remodeling in asthma. CXCL1 chemokine has been linked to tissue growth and metastasis. In this study, we present a detailed examination of the inhibitory effect of CXCL1 on human primary ASMC migration and the role of the decoy receptor, Duffy AgR for chemokines (DARC), in this inhibition. Western blots and pathway inhibitors showed that this phenomenon was mediated by activation of the ERK-1/2 MAPK pathway, but not p38 MAPK or PI3K, suggesting a biased selection in the signaling mechanism. Despite being known as a nonsignaling receptor, small interference RNA knockdown of DARC showed that ERK-1/2 MAPK activation was significantly dependent on DARC functionality, which, in turn, was dependent on the presence of heat shock protein 90 subunit α. Interestingly, DARC- or heat shock protein 90 subunit α-deficient ASMCs responded to CXCL1 stimulation by enhancing p38 MAPK activation and ASMC migration through the CXCR2 receptor. In conclusion, we demonstrated DARC's ability to facilitate CXCL1 inhibition of ASMC migration through modulation of the ERK-1/2 MAPK-signaling pathway.